Psychiatry and Neurology, Neurology · Honolulu, HI
NPI
1477523785
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
250 Ward Ave Ste 170
Honolulu, HI, 96814
Phone (808) 294-3332
Groups this clinician bills Medicare through
Medicare paid, 2024
$280K
1,924 services
Medicare patients, 2024
416
Average age 74
Drug cost, 2024
$1.7M
1,605 prescriptions
Company payments, 2025
$3,390
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Russo was code 99215 (office e&m - established), 903 times for 354 patients. In total Michael B Russo billed 1,924 services in 17 codes, and Medicare paid $280K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 903 | 354 | $124.05 | $112K |
| 95819 Neurologic | Office | 253 | 206 | $351.13 | $89K |
| 96138 Behavioral Health Services | Office | 181 | 179 | $26.89 | $4,868 |
| 96132 Behavioral Health Services | Office | 181 | 179 | $88.96 | $16K |
| 99205 Office E&M - New | Office | 174 | 174 | $142.48 | $25K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 112 | 111 | $70.86 | $7,936 |
| 95816 Neurologic | Office | 36 | 28 | $307.48 | $11K |
| 99214 Office E&M - Established | Office | 32 | 28 | $112.31 | $3,594 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 17 | 17 | $23.53 | $400 |
| 95807 Sleep Study | Office | 12 | 12 | $327.98 | $3,936 |
By year: 2022 $334K for 1,857 services; 2023 $348K for 2,082 services; 2024 $280K for 1,924 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Russo prescribed most often to Medicare patients was Lacosamide, with 168 prescriptions and refills. In total Michael B Russo wrote 1,605 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 168 | 237 | 33 | $19K |
| Trazodone Hcl Generic | 145 | 394 | 52 | $1,501 |
| Horizant Gabapentin Enacarbil | 83 | 94 | 18 | $107K |
| Mirtazapine Generic | 64 | 148 | 21 | $2,124 |
| Neupro Rotigotine | 54 | 104 | 12 | $89K |
| Oxtellar Xr Oxcarbazepine | 50 | 82 | Under 11 | $67K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 48 | 109 | 12 | $585 |
| Levetiracetam Generic | 45 | 95 | Under 11 | $1,375 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 40 | 50 | Under 11 | $79K |
| Emgality Pen Galcanezumab-Gnlm | 40 | 40 | Under 11 | $29K |
| Fycompa Perampanel | 40 | 40 | Under 11 | $51K |
| Briviact Brivaracetam | 37 | 43 | Under 11 | $62K |
| Armodafinil Generic | 37 | 59 | Under 11 | $3,280 |
| Aimovig Autoinjector Erenumab-Aooe | 35 | 35 | Under 11 | $25K |
| Risperidone Generic | 34 | 80 | 12 | $446 |
Brand drugs: 670 claims; generic drugs: 923 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Russo $3,390 ($3,390 in general payments such as food, travel and fees) from 18 companies. The largest payer was Philips North America LLC with $1,021.
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC PHG | 1 | $1,021 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $532 |
| UCB, Inc. UCB.BR | 10 | $451 |
| Abbvie Inc. ABBV | 8 | $212 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $173 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $152 |
| Pfizer Inc. PFE | 10 | $140 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $129 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $105 |
| SK Life Science, Inc. | 3 | $93.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.